
Supplements and Featured Publications
- New Paradigms in Comorbid Insomnia
- Volume 15
- Issue 1 Suppl
Participating Faculty
FACULTY
Christina S. McCrae, PhD
Associate Professor
Department of Clinical and Health Psychology
University of Florida
Gainesville, Florida
David N. Neubauer, MD
Associate Director
Department of Psychiatry and Behavioral Sciences
Johns Hopkins Sleep Disorders Center
Baltimore, Maryland
Thomas Roth, PhD
Director
Henry Ford Hospital Sleep Disorders and Research Center
Detroit, Michigan
FACULTY DISCLOSURES
These participants report relationships with the following organizations:
Christina S. McCrae, PhD
Grants: National Institutes of Health
David N. Neubauer, MD
Consultant/Advisory board: sanofi-aventis, Takeda Pharmaceuticals
North America
Lecturer: sanofi-aventis, Takeda Pharmaceuticals North America
Thomas Roth, PhD
Consultant: Abbott, Actelion, Arena, BTG, Cephalon, Evotec, Intec,
Intra-Cellular, Jazz, Merck, Neurim, Neurocrine, Neurogen, Organon,
Pfizer, Procter & Gamble, Sanofi, Schering-Plough, Sepracor, Shire,
Somaxon, Takeda, TransOral, Vanda
Sepracor
This supplement was supported by
Articles in this issue
over 16 years ago
Current and New Thinking in the Management of Comorbid Insomniaover 16 years ago
Late-Life Comorbid Insomnia: Diagnosis and Treatmentover 16 years ago
Comorbid Insomnia: Current Directions and Future Challengesover 16 years ago
IntroductionNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.